Gland Pharma Limited (GLAND.BO)

INR 1404.7

(0.45%)

Operating Expenses Summary of Gland Pharma Limited

  • Gland Pharma Limited's latest annual operating expenses in 2023 was 3.86 Billion INR , down -34.14% from previous year.
  • Gland Pharma Limited's latest quarterly operating expenses in 2024 Q1 was 1.71 Billion INR , up 0.64% from previous quarter.
  • Gland Pharma Limited reported a annual operating expenses of 10.19 Billion INR in annual operating expenses 2022, up 16.61% from previous year.
  • Gland Pharma Limited reported a annual operating expenses of 8.74 Billion INR in annual operating expenses 2021, up 20.12% from previous year.
  • Gland Pharma Limited reported a quarterly operating expenses of 1.58 Billion INR for 2024 Q2, down -7.53% from previous quarter.
  • Gland Pharma Limited reported a quarterly operating expenses of 6.09 Billion INR for 2023 Q2, up 15.54% from previous quarter.

Annual Operating Expenses Chart of Gland Pharma Limited (2023 - 2017)

Historical Annual Operating Expenses of Gland Pharma Limited (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 3.86 Billion INR -34.14%
2022 10.19 Billion INR 16.61%
2021 8.74 Billion INR 20.12%
2020 7.28 Billion INR 19.89%
2019 6.07 Billion INR 16.27%
2018 5.22 Billion INR 13.26%
2017 4.61 Billion INR 0.0%

Peer Operating Expenses Comparison of Gland Pharma Limited

Name Operating Expenses Operating Expenses Difference
Abbott India Limited 5.98 Billion INR 35.491%
Cipla Limited 59.21 Billion INR 93.479%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR 11.377%
Kopran Limited 859.54 Million INR -349.26%
Marksans Pharma Limited 3.28 Billion INR -17.394%
NGL Fine-Chem Limited 816.16 Million INR -373.141%
Pfizer Limited 4.33 Billion INR 10.965%
Sanofi India Limited 3.69 Billion INR -4.566%
SMS Pharmaceuticals Limited 370.89 Million INR -941.166%